SCHEMBL5756395

SCHEMBL5756395

O=C(Nc1ccc(F)cc1)c1cc([N+](=O)[O-])cc2c(O)nc(Nc3ccc(F)c(C(F)(F)F)c3)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ P2RX1 P51575 3/20 0.39
▸ TMPRSS4 Q9NRS4 1/20 0.39
▸ MAPT P10636 5/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ P2RX4 Q99571 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ PIN1 Q13526 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ GRM4 Q14833 1/20 0.38
▸ MDM2 Q00987 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ MEN1 O00255 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5753538 0.80 MAPT (0.44) P2RX1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL5753186 0.79 PIN1 (0.45) MAPTPIN1MEN1KMT2APOLB
SCHEMBL5752319 0.79 SMN1; SMN2 (0.45) P2RX1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL12264711 0.78 NQO2 (0.41) MAPTSMN1; SMN2NPC1RAB9APIN1
SCHEMBL5755383 0.77 PIK3CA (0.42) MAPTSMN1; SMN2PIN1ALDH1A1RXFP1
SCHEMBL5752579 0.77 MEN1 (0.49) P2RX1MAPTSMN1; SMN2PIN1LMNA
SCHEMBL5755373 0.73 KMT2A (0.48) P2RX1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL18147725 0.71 P2RX1 (0.56) P2RX1TMPRSS4MAPTSMN1; SMN2NPC1
SCHEMBL14461134 0.71 PIN1 (0.40) MAPTSMN1; SMN2NPC1RAB9APIN1
SCHEMBL5754027 0.70 MEN1 (0.49) HDAC3HDAC1HDAC2HDAC6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218358-B1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2006-09-13 — — EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 — — US disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback